MedPh Online - Page 5

Lithium carbonate generics may look the same, but different formulations can change your blood levels. Learn why serum monitoring is critical, how brand switches affect safety, and what target levels you should aim for in bipolar disorder treatment.

Not all beta-blockers are the same. Learn how different types like carvedilol, nebivolol, and propranolol work differently for heart failure, hypertension, and asthma-and why choosing the right one matters for your health.

Scopolamine is the most effective motion sickness medication, but its strong sedative effects can become dangerous when mixed with alcohol, sleep aids, or CBD. Learn the risks, real-world consequences, and how to use it safely.

Simplify complex medication regimens for older adults by reducing pill burden, aligning dosing times, and using combination pills. Learn how pharmacists use tools like MRS GRACE to improve adherence and independence without compromising health.

Autoimmune overlap syndromes combine features of PBC, PSC, and AIH, making diagnosis and treatment complex. Learn how to spot mixed patterns, why standard treatments often fail, and what testing is truly needed.

Generics keep global healthcare spending in check, saving billions annually. But rising drug costs, unequal access, and shrinking aid threaten their role. This is how generics shape health economics worldwide.

Asthma in children is managed best with proper spacer use, clear school care plans, and consistent training. Learn how spacers improve medication delivery, why schools must be part of the plan, and what every parent needs to know to keep their child safe.

Online reviews are shaping how patients view generic medications-even when science says they’re identical to brand names. Learn why trust matters more than pills, and how patient experiences drive adherence, side effects, and healthcare costs.

Mixing alcohol with prescription drugs can cause deadly interactions, from liver failure to respiratory arrest. Learn which medications are most dangerous, who's at highest risk, and how to protect yourself.

Drug shortages are rising sharply due to global manufacturing risks, thin profit margins, and policy failures. By 2030, critical medications like insulin, chemotherapy drugs, and antibiotics could be routinely unavailable. Here’s what’s driving the crisis-and what needs to change.

Brand companies launch authorized generics not to help patients, but to protect revenue when patents expire. These are identical drugs sold under a generic label, cutting prices while keeping market share - a strategic move that lowers costs for consumers and reshapes generic competition.

In 2025, PBC treatment has shifted dramatically after obeticholic acid was withdrawn. UDCA remains first-line, but seladelpar and elafibranor now offer effective second-line options with better safety and symptom relief.